Medindia

X

Medithrive Awarded Outstanding Cannabis Club 2010

Tuesday, April 27, 2010 Press Release J E 4
Advertisement


SAN FRANCISCO, April 26 Medithrive, Inc. has been named an Outstanding Cannabis Club 2010, by www.cannabisclubnetwork.com in recognition of its impeccable standards of quality and customer service. Along with its December 2009 Patient's Choice Award, this is Medithrive's second prestigious award for outstanding service in only its first year of operation.

Already called the number one medicinal marijuana dispensary in the Bay Area, Medithrive has continued to appeal to customers with its comfortable atmosphere, friendly staff and unbeatable pricing. Here are some of the reviews that earned Medithrive its impressive reputation:

"Finally, a great space that doesn't feel like some guy's basement." "Customer service is awesome, from the doorman to the receptionist to the budtenders." Medithrive's staff is knowledgeable, friendly and always willing to answer questions and share their experiences with specific strains.

Medithrive's rapid rise demonstrates that patients have come to value refinement and sophistication within the medicinal marijuana industry. Far from the early days of ramshackle storefronts and questionable products, the dispensaries that continue to flourish will be the ones whose patients feel comfortable and free of stigma associated with medicinal marijuana. Medithrive's patient oriented philosophy will continue to raise standards for dispensaries nationwide.

Medithrive is open seven days a week from 11 a.m. - 9 p.m. Medithrive is located at 1933 Mission Street, San Francisco, CA, telephone number: (415) 556-2000. Visit Medithrive at www.medithrive.com.

Membership is free for all but limited to those who have a recognized recommendation for the use of medicinal marijuana.

SOURCE Medithrive, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Pelosi Statement on President Obama Signing TRICAR...
S
Watson Confirms Cenestin(R) Patent Challenge